Erectile Dysfunction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Aged 20-70 years old male; 2) Healthy in general; 3) in line with the diagnosis of vascular erectile dysfunction (ED); 4) have a history of ED for at least 6 months, and no more than 7 years; 5) Past user of PDE5-i and take effective; 6) did not use PDE5-i within 4 weeks prior to grouping; 7) IIEF-EF scoure between 11 and 25; 8) a stable heterosexual relationship for at least 3 months before treatment; 9) Subject voluntarily agreed to participate in the trial and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1) ED due to hormonal, neurological or psychopathological factors; 2) patients who have got radical prostatectomy or pelvic surgery in the past; 3) any unstable medical, mental illness, spinal cord injury, abnormal penis anatomy; 4) Arterial obstruction is located in the common penile artery and cavernosal artery; 5) The penis is implanted in the prosthesis; 6) recovering from cancer in the past year; 7) clinically significant chronic hematological diseases; 8) venous leak has been confirmed; 9) poor blood pressure control (systolic blood pressure after treatment = 160mmHg and diastolic blood pressure = 100mmHg); 10) poor glycemic control after treatment, FPG after treatment> 7.0 mmol / l (126 mg / dl); 11) anti-androgens, either orally or injection; 12) pelvic radiotherapy postoperation; 13) Coagulation disorders and use of anticoagulants such as Coumadin; 14) Have participated in any other medical device or drug clinical research in the past three months; 15) Patients unsuitable for this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IIEF-EF;Pain;ERY, LEU, PRO, GLU;hematoma;hematuria;Ecchymosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| SEP;GAQ;EHS;BUN, CR;glucose;X-ray;RBC, WBC, NEUT, HGB, PLT;AST, ALT, GGT;ECG; | — |
Countries
China
Contacts
Peking University 1st Hospital